<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>Comments on: Court Revises Opinion on Amgen Case with ITC</title>
	<atom:link href="http://www.patentbaristas.com/archives/2009/05/07/court-revises-opinion-on-amgen-case-with-itc/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2009/05/07/court-revises-opinion-on-amgen-case-with-itc/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=court-revises-opinion-on-amgen-case-with-itc</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Tue, 07 Feb 2012 11:57:58 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Topics about Beijing &#124; Court Revises Opinion on Amgen Case with ITC</title>
		<link>http://www.patentbaristas.com/archives/2009/05/07/court-revises-opinion-on-amgen-case-with-itc/comment-page-1/#comment-68072</link>
		<dc:creator>Topics about Beijing &#124; Court Revises Opinion on Amgen Case with ITC</dc:creator>
		<pubDate>Fri, 08 May 2009 09:12:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/?p=1537#comment-68072</guid>
		<description>[...] Patent Baristas placed an interesting blog post on Court Revises Opinion on Amgen Case with ITCHere&#8217;s a brief overviewEarlier, Amgen tried to stop the importation of recombinant human erythropoietin and derivatives (EPO) by filing a complaint with the International Trade Commission that is was a violation of Section 337 of the Tariff Act of 1930 . Amgen charged that the imported EPO and the process by which it is produced in Europe are covered by one or more claims of the following Amgen patents:  Pat. Nos. 5,411,868, 5,547,933, 5,618,698, 5,621,080, 5,756,349 and 5,955,422. In related news, this new for [...]</description>
		<content:encoded><![CDATA[<p>[...] Patent Baristas placed an interesting blog post on Court Revises Opinion on Amgen Case with ITCHere&#8217;s a brief overviewEarlier, Amgen tried to stop the importation of recombinant human erythropoietin and derivatives (EPO) by filing a complaint with the International Trade Commission that is was a violation of Section 337 of the Tariff Act of 1930 . Amgen charged that the imported EPO and the process by which it is produced in Europe are covered by one or more claims of the following Amgen patents:  Pat. Nos. 5,411,868, 5,547,933, 5,618,698, 5,621,080, 5,756,349 and 5,955,422. In related news, this new for [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: www.patentbaristas.com @ 2012-02-12 18:58:24 -->
